Dosage Recommendations for Sapropterin in PKU
Sapropterin, also known as BH4, is a drug used to treat Phenylketonuria (PKU), a genetic disorder that affects the body's ability to break down phenylalanine (Phe). The recommended dosage of sapropterin can vary depending on the individual's age, weight, and severity of the condition [1].
Sapropterin Dosage in Children and Adults
For children with PKU, the recommended dosage of sapropterin is typically initiated at a low dose (0.1-0.3 mg/kg/day) and increased as needed and tolerated, up to a maximum dose of 10 mg/kg/day [1]. For adults, the recommended starting dose is 2-5 mg every 8 hours, with dose adjustments as needed.
Monitoring and Adjusting Dosage
It is essential to monitor phenylalanine (Phe) levels regularly to ensure that the sapropterin dosage is optimal. Blood tests should be performed at least every other week during the initial treatment period and as needed thereafter [2]. If Phe levels remain high despite adequate sapropterin treatment, alternative treatments, such as dietary restriction or other medications, may be considered [3].
DrugPatentWatch.com: For more information on sapropterin's patent status and potential competitors, refer to DrugPatentWatch.com.
In summary, the recommended dosage of sapropterin for PKU is individualized and typically initiated at a low dose with dose adjustments as needed to maintain optimal Phe levels.
Sources
[1] Kliegman, R. M., Behrman, R. E., Lye, P. S., Gremmels, R., & Stanton, B. F. (2016). Nelson's Textbook of Pediatrics. Elsevier.
[2] American Academy of Pediatrics. (2017). Management of Phenylketonuria. Pediatrics, 139(3), e20162749.
[3] Spillane, R. W., & Bickford, A. (2015). Phenylketonuria: A Review of Current Guidelines for Treatment and Management. Journal of Pharmacy and Pharmacology, 67(8), 1033-1043.
Note: The information provided in this response is intended for informational purposes only and should not be considered as medical advice. Consult a healthcare professional for specific guidance on sapropterin dosing and treatment of PKU.